Litaizhi Pharmaceutical Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $7.46M

  • Investors
  • 3

Litaizhi Pharmaceutical General Information

Description

Developer of innovative peptide drugs designed to accelerate pharmaceutical research through artificial intelligence. The company utilizes generative artificial intelligence, peptide generation models, mirror-peptide design, synthetic data generation, transformer architectures, and closed-loop experimental validation, thereby enabling pharmaceutical partners to design cyclic and D-type peptides for oncology, autoimmune, and metabolic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rooms 409 and 410, 4th Floor
  • Number 123 Zhongguancun North Street, Haidian District
  • Beijing
  • China
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Business/Productivity Software
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Rooms 409 and 410, 4th Floor
  • Number 123 Zhongguancun North Street, Haidian District
  • Beijing
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Litaizhi Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 10-Oct-2026 $7.46M Completed Startup
To view Litaizhi Pharmaceutical’s complete valuation and funding history, request access »

Litaizhi Pharmaceutical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Xinglian Zhaoji Private Equity Fund Management Venture Capital Minority
iFlytek Startups Accelerator/Incubator Minority
L2F Light Source Entrepreneur Fund Angel Group Minority
To view Litaizhi Pharmaceutical’s complete investors history, request access »

Ready to get started?

Request a free trial

Litaizhi Pharmaceutical FAQs

  • When was Litaizhi Pharmaceutical founded?

    Litaizhi Pharmaceutical was founded in 2026.

  • Where is Litaizhi Pharmaceutical headquartered?

    Litaizhi Pharmaceutical is headquartered in Beijing, China.

  • What industry is Litaizhi Pharmaceutical in?

    Litaizhi Pharmaceutical’s primary industry is Discovery Tools (Healthcare).

  • Is Litaizhi Pharmaceutical a private or public company?

    Litaizhi Pharmaceutical is a Private company.

  • What is Litaizhi Pharmaceutical’s current revenue?

    The current revenue for Litaizhi Pharmaceutical is .

  • How much funding has Litaizhi Pharmaceutical raised over time?

    Litaizhi Pharmaceutical has raised $7.46M.

  • Who are Litaizhi Pharmaceutical’s investors?

    Beijing Xinglian Zhaoji Private Equity Fund Management, iFlytek Startups, and L2F Light Source Entrepreneur Fund have invested in Litaizhi Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process